162 related articles for article (PubMed ID: 11768585)
1. Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy.
Bergmann SR; Herrero P; Sciacca R; Hartman JJ; Rubin PJ; Hickey KT; Epstein S; Kelly DP
J Inherit Metab Dis; 2001 Nov; 24(6):657-74. PubMed ID: 11768585
[TBL] [Abstract][Full Text] [Related]
2. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency).
Kelly DP; Mendelsohn NJ; Sobel BE; Bergmann SR
Am J Cardiol; 1993 Mar; 71(8):738-44. PubMed ID: 8447275
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of myocardial fatty acid metabolism using PET.
Bergmann SR; Weinheimer CJ; Markham J; Herrero P
J Nucl Med; 1996 Oct; 37(10):1723-30. PubMed ID: 8862319
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid metabolism in hearts containing elevated levels of CoA.
Lopaschuk GD; Hansen CA; Neely JR
Am J Physiol; 1986 Mar; 250(3 Pt 2):H351-9. PubMed ID: 3953832
[TBL] [Abstract][Full Text] [Related]
5. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.
Fox KA; Abendschein DR; Ambos HD; Sobel BE; Bergmann SR
Circ Res; 1985 Aug; 57(2):232-43. PubMed ID: 4017196
[TBL] [Abstract][Full Text] [Related]
6. Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.
Geltman EM
J Nucl Cardiol; 1994; 1(2 Pt 2):S15-22. PubMed ID: 9420693
[TBL] [Abstract][Full Text] [Related]
7. Alterations in fatty acid metabolism in adriamycin cardiomyopathy.
Beanlands RS; Shaikh NA; Wen WH; Dawood F; Ugnat AM; McLaughlin PR; Carere R; Liu PP
J Mol Cell Cardiol; 1994 Jan; 26(1):109-19. PubMed ID: 8196063
[TBL] [Abstract][Full Text] [Related]
8. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
Knuuti J; Takala TO; Någren K; Sipilä H; Turpeinen AK; Uusitupa MI; Nuutila P
Diabetologia; 2001 Feb; 44(2):184-7. PubMed ID: 11270674
[TBL] [Abstract][Full Text] [Related]
9. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.
Herrero P; Peterson LR; McGill JB; Matthew S; Lesniak D; Dence C; Gropler RJ
J Am Coll Cardiol; 2006 Feb; 47(3):598-604. PubMed ID: 16458143
[TBL] [Abstract][Full Text] [Related]
10. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and initial evaluation of 17-(11)C-heptadecanoic acid for measurement of myocardial fatty acid metabolism.
Collier TL; Hwang Y; Ramasamy R; Sciacca RR; Hickey KT; Simpson NR; Bergmann SR
J Nucl Med; 2002 Dec; 43(12):1707-14. PubMed ID: 12468523
[TBL] [Abstract][Full Text] [Related]
12. Regional myocardial metabolic rate of oxygen measured by O2-15 inhalation and positron emission tomography in patients with cardiomyopathy.
Agostini D; Iida H; Takahashi A; Tamura Y; Henry Amar M; Ono Y
Clin Nucl Med; 2001 Jan; 26(1):41-9. PubMed ID: 11139052
[TBL] [Abstract][Full Text] [Related]
13. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.
DeGrado TR; Wang S; Holden JE; Nickles RJ; Taylor M; Stone CK
Nucl Med Biol; 2000 Apr; 27(3):221-31. PubMed ID: 10832078
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
16. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
Buxton DB; Mody FV; Krivokapich J; Schelbert HR
J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Welch MJ; Lewis JS; Kim J; Sharp TL; Dence CS; Gropler RJ; Herrero P
J Nucl Med; 2006 Apr; 47(4):689-97. PubMed ID: 16595504
[TBL] [Abstract][Full Text] [Related]
18. [Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].
Kaiser KP; Feinendegen LE
Herz; 1987 Feb; 12(1):41-50. PubMed ID: 3493962
[TBL] [Abstract][Full Text] [Related]
19. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease.
de las Fuentes L; Herrero P; Peterson LR; Kelly DP; Gropler RJ; Dávila-Román VG
Hypertension; 2003 Jan; 41(1):83-7. PubMed ID: 12511534
[TBL] [Abstract][Full Text] [Related]
20. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.
Dávila-Román VG; Vedala G; Herrero P; de las Fuentes L; Rogers JG; Kelly DP; Gropler RJ
J Am Coll Cardiol; 2002 Jul; 40(2):271-7. PubMed ID: 12106931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
